Press Release
Category Added in a WPeMatico Campaign
-
Generative AI in Healthcare Market to Reach $30.4 Billion by 2032 at 34.9% CAGR
Increasing prevalence of bleeding disorders, rising number of surgical procedures, aging population, and growing focus on interoperability are the major…
Read More » -
Introducing DROS.ai: Reinventing debt recovery through Intelligent Engagement
AI-powered engagement platform for collection agencies, debt buyers, and recovery teams Engages debtors at the right time and on the…
Read More » -
QED Connect (OTCMKTS:QEDN) Launches its Valhalla Wulff Eco-Friendly and GMSacha Inchi Food Stations Project in Medellin, Colombia, with Charging Stations for New Cars Like Tesla and BYD
Albany, USA QED Connect with a ticker QEDN listed on the OTC Markets is launching its first Valhalla Wulff project,…
Read More » -
QED Connect (OTCMKTS:QEDN) Launches its Valhalla Wulff Eco-Friendly and GMSacha Inchi Food Stations Project in Medellin, Colombia, with Charging Stations for New Cars Like Tesla and BYD
Albany, USA QED Connect with a ticker QEDN listed on the OTC Markets is launching its first Valhalla Wulff project,…
Read More » -
REKIZ LLC Introduces AI Smart Glasses Designed for Everyday Use in Expanding Wearables Market
REKIZ LLC introduces its Apex and Nova AI smart glasses, highlighting a shift toward practical wearable technology that integrates real-time…
Read More » -
Forsyth Advisors Promotes Nate Beckermann to Lead Diligence Efforts, Strengthening Investment-Stage Capabilities
ST. LOUIS, April 27, 2026 /PRNewswire/ — Forsyth Advisors today announces the promotion of Nate Beckermann (Vice President, Due Diligence…
Read More » -
Electrosoft Names Former USPTO CIO Jamie Holcombe as COO
Veteran fed tech executive brings deep cyber and AI modernization expertise RESTON, Va., April 27, 2026 /PRNewswire/ — Electrosoft Services,…
Read More » -
FDA grants Priority Review for IMAAVY® (nipocalimab-aahu) as the potential first approved treatment for people living with warm autoimmune hemolytic anemia (wAIHA)
Priority Review is granted to medicines that may offer significant improvements in safety or effectiveness for serious conditions like warm…
Read More » -
TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University
BOSTON, April 27, 2026 /PRNewswire/ — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering RNA and immuno-oncology therapeutics…
Read More »
